These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 32315384)
1. A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice. Miszta A; Kopec AK; Pant A; Holle LA; Byrnes JR; Lawrence DA; Hansen KC; Flick MJ; Luyendyk JP; de Laat B; Wolberg AS Blood; 2020 May; 135(19):1704-1717. PubMed ID: 32315384 [TBL] [Abstract][Full Text] [Related]
2. Sex-dependent balance between thrombin and plasmin generation in the presence of thrombomodulin. Tarandovskiy ID; Buehler PW; Karnaukhova E J Thromb Thrombolysis; 2023 Apr; 55(3):566-570. PubMed ID: 36508084 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Matsumoto T; Nogami K; Shima M Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166 [TBL] [Abstract][Full Text] [Related]
4. Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin. Tarandovskiy ID; Rajabi AA; Karnaukhova E; Buehler PW J Thromb Thrombolysis; 2019 Jul; 48(1):81-87. PubMed ID: 31030323 [TBL] [Abstract][Full Text] [Related]
6. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1. Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230 [TBL] [Abstract][Full Text] [Related]
7. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor. Morishima Y; Honda Y J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711 [TBL] [Abstract][Full Text] [Related]
8. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans. Mao SS; Cooper CM; Wood T; Shafer JA; Gardell SJ J Biol Chem; 1999 Dec; 274(49):35046-52. PubMed ID: 10574983 [TBL] [Abstract][Full Text] [Related]
9. Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery. Miszta A; Ahmadzia HK; Luban NLC; Li S; Guo D; Holle LA; Berger JS; James AH; Gobburu JVS; van den Anker J; de Laat B; Wolberg AS J Thromb Haemost; 2021 Jan; 19(1):221-232. PubMed ID: 33001565 [TBL] [Abstract][Full Text] [Related]
10. A history of early stent thrombosis is associated with prolonged clot lysis time. Pankiw-Bembenek O; Zalewski J; Goralczyk T; Undas A Thromb Haemost; 2012 Mar; 107(3):513-20. PubMed ID: 22274545 [TBL] [Abstract][Full Text] [Related]
11. Plasmin and the thrombin-thrombomodulin complex both contribute to thrombin-activatable fibrinolysis inhibitor activation in whole blood model thrombi. Vercauteren E; Mutch NJ; Declerck PJ; Gils A J Thromb Haemost; 2013 Jan; 11(1):190-2. PubMed ID: 23140098 [No Abstract] [Full Text] [Related]
13. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon. Binette TM; Taylor FB; Peer G; Bajzar L Blood; 2007 Nov; 110(9):3168-75. PubMed ID: 17644733 [TBL] [Abstract][Full Text] [Related]
14. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Konieczynska M; Fil K; Bazanek M; Undas A Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139 [TBL] [Abstract][Full Text] [Related]
15. Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma. Xin KZ; Chang WC; Ovanesov MV Thromb Res; 2016 Apr; 140():132-139. PubMed ID: 26632515 [TBL] [Abstract][Full Text] [Related]
16. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)]. Urano T Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380 [TBL] [Abstract][Full Text] [Related]
17. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. Bajzar L; Nesheim M; Morser J; Tracy PB J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins. Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules. Plug T; Meijers JC Thromb Res; 2016 Oct; 146():7-14. PubMed ID: 27564657 [TBL] [Abstract][Full Text] [Related]
20. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis. Koncz Z; Bagoly Z; Haramura G; Mezei ZA; Muszbek L Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]